Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BICO Group AB's change in receivables for the quarter that ended in Mar. 2026 was kr147 Mil. It means BICO Group AB's Accounts Receivable
declined by kr147 Mil
from Dec. 2025 to Mar. 2026 .
BICO Group AB's change in receivables for the fiscal year that ended in Dec. 2025 was kr-2 Mil. It means BICO Group AB's Accounts Receivable
increased by kr2 Mil
from Dec. 2024 to Dec. 2025 .
Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
BICO Group AB's Days Sales Outstanding for the
three
months ended in Mar. 2026 was 60.10.
In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. BICO Group AB's liquidation value for the
three
months ended in Mar. 2026 was kr-355 Mil.
BICO Group AB (CHIX:BICOs) Change In Receivables Explanation
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
BICO Group AB's Days Sales Outstanding for the quarter that ended in Mar. 2026 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BICO Group AB Change In Receivables Related Terms
BICO Group AB Change In Receivables Historical Data
* Premium members only.
The historical data trend for BICO Group AB's Change In Receivables can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.
Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-20 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Change In Receivables of kr-20 Mil mean?
BICO Group AB (CHIX:BICOS) has a Change In Receivables of kr-20 Mil as of Mar. 2026. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for BICO Group AB and its competitors.
Is BICO Group AB's Change In Receivables too high?
BICO Group AB's current Change In Receivables is kr-20 Mil. Overall, BICO Group AB has a GF Score™ of 64/100, reflecting its overall financial health beyond just this single metric.
How does BICO Group AB's Change In Receivables compare to ABT and SYK?
BICO Group AB's Change In Receivables of kr-20 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Medical Devices & Instruments company?
A good Change In Receivables depends on the Medical Devices & Instruments industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for BICO Group AB and its competitors. BICO Group AB's current Change In Receivables is kr-20 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BICO Group AB stock overvalued right now?
BICO Group AB (CHIX:BICOS) has a current Change In Receivables of kr-20 Mil. The stock's GF Value™ is kr104.25, compared to a current price of kr45.75 — trading 56.1% below its estimated fair value. The current Change In Receivables is kr-20 Mil. BICO Group AB's overall GF Score™ is 64/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For BICO Group AB (CHIX:BICOS), the current Change In Receivables is kr-20 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BICO Group AB (CHIX:BICOS) Overvalued in 2026?
Based on GuruFocus' analysis, BICO Group AB stock appears to be undervalued.
The current stock price of kr45.75 is trading 56.1% below its estimated GF Value™ of kr104.25.
Key valuation signals for CHIX:BICOS:
Change In Receivables: kr-20 Mil
GF Value™: kr104.25 vs. price of kr45.75 (56.1% below fair value)
No single metric tells the full story. See the CHIX:BICOS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BICO Group AB provides hardware, laboratory automation software, and products to automate and increase efficiency in workflows for pharma and biotech companies. Its portfolio includes automated workstations, lab automation software, microscopes and live-cell imaging, 3D cell culture and bioprinting, single-cell dispensing, liquid handling, mixing technologies, and consumables. The Group operates through two segments: Life Science Solutions, the maximum revenue generator, including CYTENA, DISPENDIX, Discover Echo, QInstruments, SCIENION, Cellenion, CELLINK, and BioMatrix, and Lab Automation, consisting of Biosero, which provides the Green Button Go Suite software and automation integration services.
64GF Score
Get the complete analysis for CHIX:BICOS
Change In Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:BICOS has been successfully added to your 
